Table 3.

RT-PCR Analysis of Retrovirus Receptor mRNA in BM HSC From Untreated and G-CSF– and SCF-Treated Mice

amphoR ecoR
Untreated mice  
 Unfractionated (9)  0.49 ± 0.12* 1.16 ± 0.47  
 FR25 Lin c-kitHI (3)  0.05 ± 0.04 0.49 ± 0.25  
 FR30 Lin c-kitHI(2)  0.12 ± 0.04 Not done  
 FR35 Linc-kitHI (7)  0.14 ± 0.02 1.10 ± 0.33 
Cytokine-injected mice 
 Unfractionated (3) 0.86 ± 0.23 1.53 ± 0.51  
 FR25 Linc-kitHI (2)  0.39 ± 0.37  0.61 ± 0.33 
 FR30 Lin c-kitHI (2) 0.30 ± 0.20  0.67 ± 0.35  
 FR35 Linc-kitHI (2)  0.39 ± 0.06  0.81 ± 0.05 
NIH-3T3  1.0  1.0 
amphoR ecoR
Untreated mice  
 Unfractionated (9)  0.49 ± 0.12* 1.16 ± 0.47  
 FR25 Lin c-kitHI (3)  0.05 ± 0.04 0.49 ± 0.25  
 FR30 Lin c-kitHI(2)  0.12 ± 0.04 Not done  
 FR35 Linc-kitHI (7)  0.14 ± 0.02 1.10 ± 0.33 
Cytokine-injected mice 
 Unfractionated (3) 0.86 ± 0.23 1.53 ± 0.51  
 FR25 Linc-kitHI (2)  0.39 ± 0.37  0.61 ± 0.33 
 FR30 Lin c-kitHI (2) 0.30 ± 0.20  0.67 ± 0.35  
 FR35 Linc-kitHI (2)  0.39 ± 0.06  0.81 ± 0.05 
NIH-3T3  1.0  1.0 

The number of samples are shown in parentheses. Receptor mRNA levels were quantified based on the level of β2-m mRNA in the same sample. They were then normalized to the levels in NIH-3T3 receptor mRNA and compared with the level of the receptor mRNA in unfractionated BM.

*

Mean ± SD of the mRNA levels relative to the level in NIH-3T3 cells.

P < .01 compared with unfractionated control BM.

Cytokine-injected mice received 200 μg G-CSF/kg/d and 50 μg SCF/kg/d for 5 days. BM cells were collected 14 days later.

or Create an Account

Close Modal
Close Modal